Beacon Investment Advisory Services’s Bio-Rad Laboratories Class A BIO Stock Holding History

Beacon Investment Advisory Services’s Portfolio BIO Stock Details BIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$221K	Hold	753	–	–	0.01%	244
2026 Q1	$210K	Hold	753	–	–	0.01%	237
2025 Q4	$228K	Hold	753	–	–	0.01%	246
2025 Q3	$211K	Buy	+753	New	+$205K	0.01%	243
2025 Q1	–	Sell	-753	Closed	-$247K	–	241
2024 Q4	$247K	Hold	753	–	–	0.01%	226
2024 Q3	$252K	Hold	753	–	–	0.01%	232
2024 Q2	$206K	Hold	753	–	–	0.01%	251
2024 Q1	$260K	Hold	753	–	–	0.01%	236
2023 Q4	$243K	Hold	753	–	–	0.01%	240
2023 Q3	$270K	Hold	753	–	–	0.01%	240
2023 Q2	$285K	Hold	753	–	–	0.01%	242
2023 Q1	$361K	Hold	753	–	–	0.02%	211
2022 Q4	$317K	Hold	753	–	–	0.02%	226
2022 Q3	$314K	Hold	753	–	–	0.02%	227
2022 Q2	$373K	Hold	753	–	–	0.02%	219
2022 Q1	$424K	Hold	753	–	–	0.02%	225
2021 Q4	$569K	Hold	753	–	–	0.02%	204
2021 Q3	$562K	Hold	753	–	–	0.02%	200
2021 Q2	$485K	Hold	753	–	–	0.02%	209
2021 Q1	$430K	Hold	753	–	–	0.02%	212
2020 Q4	$439K	Hold	753	–	–	0.02%	193
2020 Q3	$388K	Hold	753	–	–	0.02%	184
2020 Q2	$340K	Hold	753	–	–	0.02%	188
2020 Q1	$264K	Hold	753	–	–	0.02%	205
2019 Q4	$279K	Hold	753	–	–	0.01%	223
2019 Q3	$251K	Hold	753	–	–	0.03%	211
2019 Q2	$235K	Hold	753	–	–	0.02%	212
2019 Q1	$230K	Buy	+753	New	+$203K	0.02%	211
2018 Q4	–	Sell	-753	Closed	-$236K	–	253
2018 Q3	$236K	Hold	753	–	–	0.02%	241
2018 Q2	$217K	Buy	+753	New	+$208K	0.02%	238

Other funds holding BIO

First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Beacon Investment Advisory Services's BIO Position: Q2 2026 in Review

Beacon Investment Advisory Services held its Bio-Rad Laboratories Class A (BIO) position steady in Q2 2026 at 753 shares worth $221K. The position accounts for 0.01% of the portfolio, ranked #244.

Beacon Investment Advisory Services first reported a position in BIO in Q2 2018 and has held it in 30 quarters since. The position peaked at $569K in Q4 2021. 397 funds tracked by Wall St. Rank hold BIO as of Q2 2026.

Beacon Investment Advisory Services held 753 shares of Bio-Rad Laboratories Class A worth $221K as of Q2 2026.
Beacon Investment Advisory Services left its Bio-Rad Laboratories Class A share count unchanged in Q2 2026.
Bio-Rad Laboratories Class A made up 0.01% of Beacon Investment Advisory Services's portfolio in Q2 2026, its #244 holding.
Beacon Investment Advisory Services first reported a position in Bio-Rad Laboratories Class A in Q2 2018 and has held it in 30 quarters since.
Beacon Investment Advisory Services's Bio-Rad Laboratories Class A position peaked at $569K in Q4 2021.
397 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q2 2026.

Based on Beacon Investment Advisory Services's 13F filing for Q2 2026, filed 8 Jul 2026.